Abstract
The advent of atypical antipsychotics greatly changed the treatment pattern for mental illnesses worldwide. This study was designed to determine the trend in prevalence, prescribing pattern, and cost of antipsychotic agents in Taiwan from 1997 to 2001. Data were obtained from claims completed for a random sample of 200,000 people registered with the National Health Insurance program. The antipsychotics monitored included all group N05A drugs in the Anatomical Therapeutic Chemical classification system (version 2000). Conventional and atypical antipsychotics were handled separately. Of the 195,971 eligible registrants, 37,441 (19.1%) received any kind of antipsychotic during this 5-year period, but only 713 (0.4%) used atypical antipsychotics. The prevalence of conventional antipsychotic use during each successive year of this study was 5.2%, 5.7%, 6.6%, 6.2%, and 6.1% and 0.1%, 0.1%, 0.1%, 0.2%, and 0.3% for atypical agents. Although far fewer registrants used them, atypicals comprised 19.1% of all prescribed amounts measured in defined daily doses and 56.1% of the cost for all antipsychotics in 2001. During the 5-year study period, atypical antipsychotics were prescribed for 405 (57%) patients with schizophrenia, 132 (19%) with affective disorder, 128 (18%) with other psychiatric disorders, and 48 (7%) with a non-psychiatric disorder. With the loosening of reimbursement restrictions in 2002, continued growth of atypical antipsychotic use in Taiwan might be expected.
Similar content being viewed by others
References
Martin BC, Miller LS, Kotzan JA. Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: current trends and five year time series forecasts.Schizophr Res. 2001;47:281–292.
Leslie DL, Rosenheck R. The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.J Nerv Ment Dis. 2001;189:377–383.
Dewa CS, Goering P. Lessons learned from trends in psychotic drug expenditures in a Canadian province.Psychiatr Serv. 2001;52:1245–1247.
Hermann RC, Yang D, Ettner SL, Marcus SC, Yoon C, Abraham M. Prescription of antipsychotic drugs by office-based physicians in the United States, 1989–1997.Psychiatr Serv. 2002;53:425–430.
Daumit GL, Crum RM, Guallar E, et al. Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States.Arch Gen Psychiatry. 2003;60:121–128.
Mond J, Morice R, Owen C, Korten A. Use of antipsychotic medications in Australia between July 1995 and December 2001.Aust NZ J Psychiatry. 2003;37:55–61.
Bureau of National Health Insurance.2001 National Health Insurance Annual Statistical Report. Taipei, Taiwan: Bureau of National Health Insurance; 2002.
Su TP, Chen TJ, Hwang SJ, Chou LF, Fan AP, Chen YC. Utilization of psychotropic drugs in Taiwan: an overview of outpatient sector in 2000.Zhonghua Yi Xue Za Zhi (Taipei). 2002;65:378–391.
Chen TJ, Chou LF, Hwang SJ. Trends in prescribing proton pump inhibitors in Taiwan: 1997–2000.Int J Clin Pharmacol Ther. 2003;41:207–212.
Chen TJ, Chou LF, Hwang SJ. Prevalence of anti-ulcer drug use in a Chinese cohort.World J Gastroenterol. 2003;9:1365–1369.
Chen TJ, Chou LF, Hwang SJ. Utilization of hepatoprotectants within the National Health Insurance in Taiwan.J Gastroenterol Hepatol. 2003;18:868–872.
Chen TJ, Chou LF, Hwang SJ. Application of a data-mining technique to analyze coprescription patterns for antacids in Taiwan.Clin Ther. 2003;25:2453–2463.
WHO Collaborating Centre for Drug Statistics Methodology.Guidelines for ATC Classification and DDD Assignment, 3rd ed. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2000.
Gareri P, De Fazio P, Stilo M, Ferreri G, De Sarro G. Conventional and atypical antipsychotics in the elderly: a review.Clin Drug Invest. 2003;23:287–322.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chou, LF. Patterns and costs of antipsychotic drug use in Taiwan: 1997 to 2001. Adv Therapy 20, 344–351 (2003). https://doi.org/10.1007/BF02849801
Issue Date:
DOI: https://doi.org/10.1007/BF02849801